Literature DB >> 11733109

Enhanced oxidative damage in human cells harboring A3243G mutation of mitochondrial DNA: implication of oxidative stress in the pathogenesis of mitochondrial diabetes.

C Y Pang1, H C Lee, Y H Wei.   

Abstract

Mitochondrial oxidative phosphorylation and the ATP production in pancreatic beta cells play significant roles in insulin secretion in response to glucose and other nutrients. An A to G mutation in the tRNA(Leu(UUR)) gene at nucleotide position (np) 3243 of mitochondrial DNA (mtDNA) has been observed in patients with MELAS syndrome and mitochondrial diabetes. Recently, some patients with mitochondrial diabetes associated with the A3243G mtDNA mutation were found to respond to coenzyme Q10 therapy. Thus, we investigated oxidative stress and peroxidative damage in a series of cybrids carrying either the wild-type adenine or the mutant-type guanine at np 3243 but having otherwise identical mtDNA sequence. The cybrids harboring >90% of the A3243G mutant mtDNA were found to have significantly lower oxygen consumption rate and electron transfer activities, and thereby had lower ATP/ADP ratios and declined energy charge. Importantly, the defective respiratory function elicited by the A3243G mtDNA mutation caused an increased oxidative stress as indicated by the decreased GSH/GSSG ratio and enhanced oxidative damage to lipids. Moreover, the cybrids harboring high proportions of the A3243G mtDNA mutation were found to be much more vulnerable to an exogenous oxidant, tert-butylhydroperoxide. We thus suggest that enhanced oxidative damage and elevated oxidative stress contribute to the decline of mitochondrial function and may be involved in the initiation and progression of the MELAS syndrome and mitochondrial diabetes.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11733109     DOI: 10.1016/s0168-8227(01)00335-7

Source DB:  PubMed          Journal:  Diabetes Res Clin Pract        ISSN: 0168-8227            Impact factor:   5.602


  9 in total

1.  Metabolically induced heteroplasmy shifting and l-arginine treatment reduce the energetic defect in a neuronal-like model of MELAS.

Authors:  Valerie Desquiret-Dumas; Naig Gueguen; Magalie Barth; Arnaud Chevrollier; Saege Hancock; Douglas C Wallace; Patrizia Amati-Bonneau; Daniel Henrion; Dominique Bonneau; Pascal Reynier; Vincent Procaccio
Journal:  Biochim Biophys Acta       Date:  2012-01-28

Review 2.  Oxidative stress in inherited mitochondrial diseases.

Authors:  Genki Hayashi; Gino Cortopassi
Journal:  Free Radic Biol Med       Date:  2015-06-12       Impact factor: 7.376

Review 3.  MELAS syndrome and cardiomyopathy: linking mitochondrial function to heart failure pathogenesis.

Authors:  Ying-Han R Hsu; Haran Yogasundaram; Nirmal Parajuli; Lucas Valtuille; Consolato Sergi; Gavin Y Oudit
Journal:  Heart Fail Rev       Date:  2016-01       Impact factor: 4.214

4.  Hepatic encephalopathy: An approach to its multiple pathophysiological features.

Authors:  Juan Carlos Perazzo; Silvina Tallis; Amalia Delfante; Pablo Andrés Souto; Abraham Lemberg; Francisco Xavier Eizayaga; Salvador Romay
Journal:  World J Hepatol       Date:  2012-03-27

5.  Mitochondrial dysfunction and mitochondrial DNA mutations in atherosclerotic complications in diabetes.

Authors:  Dimitry A Chistiakov; Igor A Sobenin; Yuri V Bobryshev; Alexander N Orekhov
Journal:  World J Cardiol       Date:  2012-05-26

6.  Characterization of human GTPBP3, a GTP-binding protein involved in mitochondrial tRNA modification.

Authors:  Magda Villarroya; Silvia Prado; Juan M Esteve; Miguel A Soriano; Carmen Aguado; David Pérez-Martínez; José I Martínez-Ferrandis; Lucía Yim; Victor M Victor; Elvira Cebolla; Asunción Montaner; Erwin Knecht; M-Eugenia Armengod
Journal:  Mol Cell Biol       Date:  2008-10-13       Impact factor: 4.272

7.  The m.3243A>G mtDNA mutation is pathogenic in an in vitro model of the human blood brain barrier.

Authors:  Mercy M Davidson; Winsome F Walker; Evelyn Hernandez-Rosa
Journal:  Mitochondrion       Date:  2009-08-12       Impact factor: 4.160

8.  Chemical reversal of abnormalities in cells carrying mitochondrial DNA mutations.

Authors:  Hiroki Kobayashi; Hideyuki Hatakeyama; Haruna Nishimura; Mutsumi Yokota; Sadafumi Suzuki; Yuri Tomabechi; Mikako Shirouzu; Hiroyuki Osada; Masakazu Mimaki; Yu-Ichi Goto; Minoru Yoshida
Journal:  Nat Chem Biol       Date:  2020-11-09       Impact factor: 15.040

Review 9.  Cellular Stress in the Pathogenesis of Muscular Disorders-From Cause to Consequence.

Authors:  Alexander Mensch; Stephan Zierz
Journal:  Int J Mol Sci       Date:  2020-08-13       Impact factor: 5.923

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.